Merck KGaA Aiming For Improvisation On Its Various Verticals And Hiring Talent
The German drug manufacturer is looking for hiring and improvising their Research and Development part. In the hiring segment, Merk will look for more talent in India. The German drug company is also expecting to collaborate with the Indian biotech firms contract research organisations for development, manufacturing and co-commercialization opportunities.
In his recent interview with ET, Global R&D Head, Danny Bar-Zohar said “There is a huge pressure on pharma because every single attempt to get drugs reimbursed is looked at and scrutinised and the pressure is very high on prices. There are other macro pressures. Inflation, gas prices, everything's squeezing us to try to do things differently,” Last week, Merck opened its R&D Excellence Centre. The global Head informed the centre will employ 300 people and will expand subsequently.
Prior to this, Bar-Zohar as the global head of clinical development and analytics at swiss drugmaker Novartis, Bar-Zohar has been setting up such a centre of Excellence in Hyderabad.
Bar- Zohar explained that the elements that can affect the R&D are the probability of success and speed ‘’It's cruel. but most of what we do fails. That’s R&D in healthcare, there is a cost of failure.” added the global head of Merck. He emphasised the role of technology and data analysis in order to cut the lead times and precious capital by predicting the probability of drug candidates.
